Actinium Pharmaceuticals, Inc. Share Price
Equities
ATNM
US00507W2061
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.03 USD | +2.33% | +0.29% | +35.24% |
Sales 2024 * | 189K 15.79M | Sales 2025 * | 69.3M 5.78B | Capitalization | 205M 17.07B |
---|---|---|---|---|---|
Net income 2024 * | -59M -4.92B | Net income 2025 * | -2M -167M | EV / Sales 2024 * | 1,043 x |
Net cash position 2024 * | 7.22M 603M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.95 x |
P/E ratio 2024 * |
-3.67
x | P/E ratio 2025 * |
-40
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.84% |
1 day | +2.33% | ||
1 week | +0.29% | ||
Current month | -12.26% | ||
1 month | -12.26% | ||
3 months | +22.68% | ||
6 months | +27.22% | ||
Current year | +35.24% |
Managers | Title | Age | Since |
---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 60 | 01/12/01 |
Steve O'Loughlin
DFI | Director of Finance/CFO | 39 | 13/15/13 |
Akash Nahar
CTO | Chief Tech/Sci/R&D Officer | - | 27/22/27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 08/13/08 | |
C. Nicholson
BRD | Director/Board Member | 68 | 01/08/01 |
Ajit Shetty
BRD | Director/Board Member | 77 | 28/17/28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
27/24/27 | 6.87 | +4.73% | 206 378 |
25/24/25 | 6.56 | -7.08% | 328,850 |
24/24/24 | 7.06 | +1.44% | 153,433 |
23/24/23 | 6.96 | -2.93% | 185,256 |
22/24/22 | 7.17 | +4.67% | 192,609 |
Delayed Quote Nyse, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.24% | 205M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.75% | 22.15B | |
-17.37% | 21.02B | |
-9.26% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ATNM Stock